Menu
 
Research menu
Jump to menu

Publications:  Dr Julia Choy

Szabados B, Abu-Ghanem Y, Grant M, Choy J, Bex A, Powles T(2020). Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors. European Urology vol. 78, (2) 276-280.
10.1016/j.eururo.2020.05.024
Abu Ghanem Y, Choy J, Jackson-Spence F, Jovaisaite A, Grant M, Bex A, Powles T, Szabados B(2020). Dynamic changes in full blood count (FBC) occurring in patients treated with immune checkpoint inhibitors (ICIs) to predict responses in patients with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology vol. 38, (15_suppl) e17110-e17110.
10.1200/jco.2020.38.15_suppl.e17110
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68239
Battisti NML, Kingston B, King J, Denton A, Waters S, Sita-Lumsden A, Rehman F, Stavraka C et al.(2019). Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience. Breast Cancer Res Treat vol. 174, (3) 731-740.
10.1007/s10549-019-05134-x
Battisti N, Kingston B, King J, Denton A, Waters S, Sita-Lumsden A, Rehman F, Stavraka C et al. (2019). Abstract P6-18-23: Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience.
10.1158/1538-7445.sabcs18-p6-18-23
Return to top